Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105722926 | 10572292 | 6 | F | 20140907 | 20160811 | 20141109 | 20160817 | EXP | US-PFIZER INC-2014305126 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105722926 | 10572292 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 2X/DAY | J06199 | 21446 | 100 | MG | CAPSULE, HARD | BID | |||||
| 105722926 | 10572292 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 105722926 | 10572292 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 105722926 | 10572292 | 4 | C | HYDROCODONE | HYDROCODONE | 1 | 7.5 MG/325 MG | 0 | |||||||||||
| 105722926 | 10572292 | 5 | C | CLONAPIN | CLONAZEPAM | 1 | 1 MG, AT BEDTIME | 0 | 1 | MG | QD | ||||||||
| 105722926 | 10572292 | 6 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 100 MG, 1X/DAY (AT BEDTIME) | 0 | 100 | MG | QD | ||||||||
| 105722926 | 10572292 | 7 | C | VERAPAMIL ER | VERAPAMIL HYDROCHLORIDE | 1 | 180 MG, 1X/DAY (Q AM) | 0 | 180 | MG | QD | ||||||||
| 105722926 | 10572292 | 8 | C | ATENOLOL. | ATENOLOL | 1 | 25 MG, DAILY | 0 | 25 | MG | |||||||||
| 105722926 | 10572292 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 50 ?G, 1X/DAY (Q AM) | 0 | 50 | UG | QD | ||||||||
| 105722926 | 10572292 | 10 | C | Duotab | 2 | 4, Q AM | 0 | QD | |||||||||||
| 105722926 | 10572292 | 11 | C | PREVACID | LANSOPRAZOLE | 1 | 15 MG, 1X/DAY | 0 | 15 | MG | QD | ||||||||
| 105722926 | 10572292 | 12 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 5000 IU, DAILY | 0 | 5000 | IU | |||||||||
| 105722926 | 10572292 | 13 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 105722926 | 10572292 | 14 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | 180 MG, DAILY | 0 | 180 | MG | |||||||||
| 105722926 | 10572292 | 15 | C | Baby ASA | ASPIRIN | 1 | UNK UNK, DAILY | 0 | |||||||||||
| 105722926 | 10572292 | 16 | C | FOLIC ACID. | FOLIC ACID | 1 | 800 MG, DAILY | 0 | 800 | MG | |||||||||
| 105722926 | 10572292 | 17 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK, DAILY | 0 | |||||||||||
| 105722926 | 10572292 | 18 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | UNK, DAILY | 0 | |||||||||||
| 105722926 | 10572292 | 19 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 4 PUFF, 2X/DAY (FLUTICASONE PROPIONATE 500, SALMETEROL XINAFOATE 50) | 0 | BID | ||||||||||
| 105722926 | 10572292 | 20 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | 12.5 MG, UNK | 0 | 12.5 | MG | |||||||||
| 105722926 | 10572292 | 21 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 22 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 23 | C | LASIX | FUROSEMIDE | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 105722926 | 10572292 | 24 | C | MUCINEX | GUAIFENESIN | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 25 | C | DULCOLAX NOS | BISACODYL OR DOCUSATE SODIUM | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 26 | C | COLACE | DOCUSATE SODIUM | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 105722926 | 10572292 | 27 | C | NITROSTAT | NITROGLYCERIN | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 28 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 29 | C | SOMA | CARISOPRODOL | 1 | 350 MG, UNK | 0 | 350 | MG | |||||||||
| 105722926 | 10572292 | 30 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | UNK (2% CREAM) | 0 | CREAM | ||||||||||
| 105722926 | 10572292 | 31 | C | QUINSANA PLUS | 2 | 0 | |||||||||||||
| 105722926 | 10572292 | 32 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 33 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK | 0 | |||||||||||
| 105722926 | 10572292 | 34 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105722926 | 10572292 | 1 | Fibromyalgia |
| 105722926 | 10572292 | 30 | Tinea pedis |
| 105722926 | 10572292 | 31 | Tinea pedis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105722926 | 10572292 | OT |
| 105722926 | 10572292 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105722926 | 10572292 | Fall | |
| 105722926 | 10572292 | Upper limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105722926 | 10572292 | 3 | 2011 | 0 | ||
| 105722926 | 10572292 | 4 | 2010 | 0 | ||
| 105722926 | 10572292 | 5 | 2010 | 0 | ||
| 105722926 | 10572292 | 6 | 2010 | 0 | ||
| 105722926 | 10572292 | 9 | 2013 | 0 |